CVE & CISA-KEV Catalog

CVE-2022-43557

MEDIUM
5.3
CVSS v3
NVD

Description

The BD BodyGuard™ infusion pumps specified allow for access through the RS-232 (serial) port interface. If exploited, threat actors with physical access, specialized equipment and knowledge may be able to configure or disable the pump. No electronic protected health information (ePHI), protected health information (PHI) or personally identifiable information (PII) is stored in the pump.

How to fix

No published remediation has been found for this vulnerability's affected products yet.

Mitigation guidance may be in the linked vendor advisories in the References section below.

CVSS v3 Vector

Exploitability

Attack VectorPhysical
Attack ComplexityHigh
Privileges RequiredNone
User InteractionNone
ScopeUnchanged

Impact

ConfidentialityLow
IntegrityLow
AvailabilityHigh

CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H

Exploit Intelligence

0.22%probability of exploitation in 30 days
12thpercentile

Low risk: more likely to be exploited than 12% of all known CVEs.

References

Vendor Advisory1
Embed a live status badge for CVE-2022-43557
CVE-2022-43557 severity badge

Markdown

[![CVE-2022-43557](https://tridentstack.com/cve/badge/CVE-2022-43557.svg)](https://tridentstack.com/cve/CVE-2022-43557)

HTML

<a href="https://tridentstack.com/cve/CVE-2022-43557"><img src="https://tridentstack.com/cve/badge/CVE-2022-43557.svg" alt="CVE-2022-43557"></a>

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2024-11-21.